OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO) LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...

WeedMD Added to Benchmark Index for Medical Marijuana ETF TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, announces its  inclusion in the...

Horizons ETFs Management (USA) LLC Appoints Head of Sales NEW YORK, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Horizons ETFs Management (USA) LLC ("Horizons USA"), a subsidiary of Mirae Asset Global Investments Co., Ltd. ("MAGI") is pleased to announce the...